Transactions
Affichage de - 333 éléments sur 968
-
US$517m
CRISPR
Co-Manager (Follow-On)
-
US$124m
AdaptHealth Corp.
Co-Manager (Follow-On)
-
N/a
Cansortium
Financial Advisor (restructuring and consent consolidation)
-
Level Ex
Financial Advisor (Sell side)
-
US$48m
TELA Bio
Lead Manager (Follow-On)
-
Undisclosed Client
N/a
Undisclosed Client
A fast growing digital media business focused on the broader consumer health space has received a significant investment from Abry Partners
-
US$74m
Castle Biosciences, Inc.
Passive Bookrunner (Follow-On)
-
US$29m
KORU Medical Systems
Joint Bookrunner (Follow-on Offering)
-
US$256m
Genetron Holdings Limited
Co-Manager (IPO)